BNT327, now in early-phase trials, is part of a class of drugs that could one day challenge Keytruda’s dominance. BioNTech ...
Haemophilia is a severe bleeding disorder caused by the deficiency of clotting Factor VIII, leading to spontaneous internal ...
In a significant medical feat, Indian scientists have developed the first-in-human gene therapy using lentiviral vectors for ...
The combined company, which will pair Chroma’s epigenetic editing with Nvelop’s non-viral particles, has raised $75 million ...
Current treatments require frequent Factor VIII replacement therapy, which faces challenges such as high costs, venous access ...
In the groundbreaking study the researchers observed an annualised zero bleeding rate in all the five subjects enrolled with ...
India has successfully conducted its first in-human gene therapy for hemophilia A, with patients experiencing no bleeding ...
BHUBANESWAR: In a significant medical breakthrough, India's first human gene therapy with a lentiviral vector for severe haemophilia-A has been found to be succ ...
In particular, patients who had fewer than 10 annual vaso-occlusive events before the gene therapy were more likely to have ...
Support the execution of a robust pipeline of customer projects for innovators developing groundbreaking in vivo and ex vivo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback